Institutional Ownership
Nrx Pharmaceuticals Inc
CUSIP 629444209COM NEWNRXPQ1 2026
13D / 13G Filings
3
Schedule 13D/13G on record
Beneficial Filers
2
Distinct reporting persons
Largest Stake
12.6%
Max % of class reported
Institutional Holders
30
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
3 filings · latest Aug 21, 2025
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | B Group, Inc. | 3.00M | $6.39M |
| 2 | Advisorshares Investments LLC | 420.5K | $895.6K |
| 3 | Commonwealth Equity Services, LLC | 397.4K | $846.5K |
| 4 | Geode Capital Management, LLC | 310.1K | $660.6K |
| 5 | Bleakley Financial Group, LLC | 117.2K | $249.6K |
| 6 | Blackrock, Inc. | 99.0K | $210.9K |
| 7 | State Street Corp | 87.0K | $185.3K |
| 8 | Xtx Topco Ltd | 78.7K | $167.7K |
| 9 | Chicago Partners Investment Group LLC | 34.5K | $102.4K |
| 10 | Jane Street Group, LLC | 44.2K | $94.0K |